Yes, certainly. Yes, as I also said, I mean, I think - tax rate improvement for us, it was about 7% in the first quarter, and that's probably about the rate. I mean, we have - like I say, good news is our international earnings are picking up. I mean, of course, we didn't get tax reform outside the U.S. So I think the 7% rate, give or take, is about the improvement we think we'll be seeing for most of the year. As far as the cash itself, bringing it back is one thing. No, we do not plan at this point anything like a special dividend or that. Certainly, as I said, one thing, we'll be spending a little bit more than on CapEx. We said we were going to be kicking that up a little bit. The other thing is I think as at the end of the year - I mean, obviously, the initial use of the cash will be to pay down debt, but we'll - yes, we're, like I said, going to spend a little bit more on CapEx, we're going to spend a little bit more on R&D. And - but the main focus of the - we still have plenty - we're still generating a lot more cash than the increases in CapEx and R&D, and the main focus of that is for acquisition. Like I said, we did a couple of small ones last year. We'll - I mean, we're looking at - we're probably looking at more than we look at right now, but I think we're being very selective in what we do. But I mean, we're conscious of that. We understand valuations have gone up, and some of that is justifiable, but we're still looking at making the same kind of returns. But, yes, I think acquisition activity is still the main focus of our cash flow, and we think we'll be able to find some that meets our criteria and are anxious to continue growth in that way. But like I said, I think we've been focusing a little bit more on organic growth as well. So those are the three - CapEx, R&D and acquisitions are still the main uses of the cash that - we will repatriate but that we generate internally.